Cargando…
PD-L1 status and Immune checkpoint inhibitors in kidney cancer: ignorance, lack of knowledge or both
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948128/ https://www.ncbi.nlm.nih.gov/pubmed/33582832 http://dx.doi.org/10.1007/s00345-021-03624-6 |
| _version_ | 1784674598901514240 |
|---|---|
| author | Tezval, Hossein Braesen, Jan Hinrich Kuczyk, Markus A. |
| author_facet | Tezval, Hossein Braesen, Jan Hinrich Kuczyk, Markus A. |
| author_sort | Tezval, Hossein |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8948128 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89481282022-04-07 PD-L1 status and Immune checkpoint inhibitors in kidney cancer: ignorance, lack of knowledge or both Tezval, Hossein Braesen, Jan Hinrich Kuczyk, Markus A. World J Urol Letter to the Editor Springer Berlin Heidelberg 2021-02-13 2022 /pmc/articles/PMC8948128/ /pubmed/33582832 http://dx.doi.org/10.1007/s00345-021-03624-6 Text en © The Author(s) 2021, corrected publication 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter to the Editor Tezval, Hossein Braesen, Jan Hinrich Kuczyk, Markus A. PD-L1 status and Immune checkpoint inhibitors in kidney cancer: ignorance, lack of knowledge or both |
| title | PD-L1 status and Immune checkpoint inhibitors in kidney cancer: ignorance, lack of knowledge or both |
| title_full | PD-L1 status and Immune checkpoint inhibitors in kidney cancer: ignorance, lack of knowledge or both |
| title_fullStr | PD-L1 status and Immune checkpoint inhibitors in kidney cancer: ignorance, lack of knowledge or both |
| title_full_unstemmed | PD-L1 status and Immune checkpoint inhibitors in kidney cancer: ignorance, lack of knowledge or both |
| title_short | PD-L1 status and Immune checkpoint inhibitors in kidney cancer: ignorance, lack of knowledge or both |
| title_sort | pd-l1 status and immune checkpoint inhibitors in kidney cancer: ignorance, lack of knowledge or both |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948128/ https://www.ncbi.nlm.nih.gov/pubmed/33582832 http://dx.doi.org/10.1007/s00345-021-03624-6 |
| work_keys_str_mv | AT tezvalhossein pdl1statusandimmunecheckpointinhibitorsinkidneycancerignorancelackofknowledgeorboth AT braesenjanhinrich pdl1statusandimmunecheckpointinhibitorsinkidneycancerignorancelackofknowledgeorboth AT kuczykmarkusa pdl1statusandimmunecheckpointinhibitorsinkidneycancerignorancelackofknowledgeorboth |